Journal of Medicinal Food,
August 2009 Issue
Read Full Study (PDF)
Dr. Boxin Ou from Brunswick Laboratories in Massachusetts conducted both studies. The purpose of the first independent randomized, double blind placebo study evaluated how Vemma enhanced immune function and well-being in humans.* Participants were randomly divided into two groups and received 2 ounces of Vemma or placebo each morning for 30 days. After the 30-day evaluation, the study showed favorable results in immune markers and a lowering of C-reactive protein (CRP) while taking Vemma.*
Changes in IL-1α Concentration (Immunity Marker)
The Vemma group improved their immune function in a statistically significant way.
Changes in IL-1α Concentration (Immunity Marker)
The Vemma group improved their immune function in a statistically significant way.
C-Reative Protein (CRP) is Reduced
in Vemma Participants
Red shaded area indicates high risk range (<1mg/L) of CRP levels. White area is low risk range of CRP levels. The Vemma group was the only group to reduce their CRP levels from unhealthy to healthy levels.
C-Reative Protein (CRP) is Reduced
in Vemma Participants
Red shaded area indicates high risk range (<1mg/L) of CRP levels. White area is low risk range of CRP levels. The Vemma group was the only group to reduce their CRP levels from unhealthy to healthy levels.
Self Reported Health Status
100% of the Vemma group reported that they felt improvement in their health, significantly more than the control group.
Self Reported Health Status
100% of the Vemma group reported that they felt improvement in their health, significantly more than the control group.
Conducted by Dr. Boxin Ou from Brunswick Laboratories in Norton, MA, the intention of these studies were to evaluate the effectiveness of a mangosteen product containing multivitamins and essential minerals, Vemma, with an independent randomized, double-blind placebo in the
